-
1
-
-
0036207348
-
The association between hepatitis C infection and survival after orthotopic liver transplantation
-
Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.
-
(2002)
Gastroenterology
, vol.122
, pp. 889-896
-
-
Forman, L.M.1
Lewis, J.D.2
Berlin, J.A.3
Feldman, H.I.4
Lucey, M.R.5
-
2
-
-
0030907160
-
Prospective study of hepatitis C virus infection after orthotopic liver transplantation
-
Barcena R, Del Campo S, Sanromán AL et al. Prospective study of hepatitis C virus infection after orthotopic liver transplantation. Transplant Proc 1997; 29: 515-516.
-
(1997)
Transplant Proc
, vol.29
, pp. 515-516
-
-
Barcena, R.1
Del Campo, S.2
Sanromán, A.L.3
-
3
-
-
0034049483
-
Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity
-
Pelletier SJ, Iezzoni JC, Crabtree TD, Hahn YS, Sawyer RG, Pruett TL. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity. Liver Transpl 2000; 6: 44-53.
-
(2000)
Liver Transpl
, vol.6
, pp. 44-53
-
-
Pelletier, S.J.1
Iezzoni, J.C.2
Crabtree, T.D.3
Hahn, Y.S.4
Sawyer, R.G.5
Pruett, T.L.6
-
4
-
-
0032899215
-
High incidence of allograft cirrhosis in HCV genotype 1b following transplantation: Relationship with rejection episodes
-
Prieto M, Berenguer M, Rayon J et al. High incidence of allograft cirrhosis in HCV genotype 1b following transplantation: Relationship with rejection episodes. Hepatology 1999; 29: 250-256.
-
(1999)
Hepatology
, vol.29
, pp. 250-256
-
-
Prieto, M.1
Berenguer, M.2
Rayon, J.3
-
5
-
-
7244247475
-
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
-
Neumann UP, Berg T, Bahra M et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004; 41: 830-836.
-
(2004)
J Hepatol
, vol.41
, pp. 830-836
-
-
Neumann, U.P.1
Berg, T.2
Bahra, M.3
-
6
-
-
18444415726
-
Contribution of donors age to the recent decrease in percents survival among HCV-infected liver transplant recipients
-
Berenguer M, Prieto M, San Juan F et al. Contribution of donors age to the recent decrease in percents survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202-210.
-
(2002)
Hepatology
, vol.36
, pp. 202-210
-
-
Berenguer, M.1
Prieto, M.2
San Juan, F.3
-
7
-
-
0037080560
-
Impact of recurrence of hepatitis C virus infection after liver transplantation on the long term viability of the graft
-
Sanchez Fueyo A, Restrepo JC, Quinto L et al. Impact of recurrence of hepatitis C virus infection after liver transplantation on the long term viability of the graft. Transplantation 2002; 73: 56-63.
-
(2002)
Transplantation
, vol.73
, pp. 56-63
-
-
Sanchez Fueyo, A.1
Restrepo, J.C.2
Quinto, L.3
-
8
-
-
0034070192
-
HCV-related fibrosis progression following liver transplantation: Increase in recent years
-
Berenguer M, Ferrell L, Watson J et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32: 673-684.
-
(2000)
J Hepatol
, vol.32
, pp. 673-684
-
-
Berenguer, M.1
Ferrell, L.2
Watson, J.3
-
9
-
-
0036073498
-
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
-
Wali M, Harrison RF, Gow PJ, Mutimer DJ. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248-252.
-
(2002)
Gut
, vol.51
, pp. 248-252
-
-
Wali, M.1
Harrison, R.F.2
Gow, P.J.3
Mutimer, D.J.4
-
10
-
-
0030933395
-
Natural history of liver fibrosis progression in patients with chronic hepatitis C
-
Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
-
(1997)
Lancet
, vol.349
, pp. 825-832
-
-
Poynard, T.1
Bedossa, P.2
Opolon, P.3
-
11
-
-
0029088814
-
An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection
-
Feray C, Samuel D, Gigou M et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-1089.
-
(1995)
Hepatology
, vol.22
, pp. 1084-1089
-
-
Feray, C.1
Samuel, D.2
Gigou, M.3
-
12
-
-
0037371521
-
Interferon alfa 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomised study
-
Samuel D, Bizollon T, Feray C et al. Interferon alfa 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomised study. Gastroenterology 2003; 124: 642-650.
-
(2003)
Gastroenterology
, vol.124
, pp. 642-650
-
-
Samuel, D.1
Bizollon, T.2
Feray, C.3
-
13
-
-
0029039362
-
Histological grading and staging of chronic hepatitis
-
Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
-
(1995)
J Hepatol
, vol.22
, pp. 696-699
-
-
Ishak, K.1
Baptista, A.2
Bianchi, L.3
-
14
-
-
1842479859
-
Diagnosis, management and treatment of hepatitis C
-
Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C. Hepatology 2004; 39: 1147-1171.
-
(2004)
Hepatology
, vol.39
, pp. 1147-1171
-
-
Strader, D.B.1
Wright, T.2
Thomas, D.L.3
Seeff, L.B.4
-
15
-
-
20544436473
-
Partial esplenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin
-
Barcena R, Gil-Grande L, Moreno J et al. Partial esplenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005; 79: 1634-1635.
-
(2005)
Transplantation
, vol.79
, pp. 1634-1635
-
-
Barcena, R.1
Gil-Grande, L.2
Moreno, J.3
-
16
-
-
0037179698
-
Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
17
-
-
0042442463
-
Hematologic disorders associated with hepatitis C virus infection and their management
-
Dieterich DT, Spivak JL. Hematologic disorders associated with hepatitis C virus infection and their management. Clin Infect Dis 2003; 37: 533-541.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 533-541
-
-
Dieterich, D.T.1
Spivak, J.L.2
-
18
-
-
10744233319
-
Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: An open-label series
-
Rodriguez-Luna H, Khatib A, Sharma P et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: An open-label series. Transplantation 2004; 77: 190-194.
-
(2004)
Transplantation
, vol.77
, pp. 190-194
-
-
Rodriguez-Luna, H.1
Khatib, A.2
Sharma, P.3
-
19
-
-
1642293907
-
Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination
-
Dumortier J, Scoazec JY, Chevallier P, Boillot O. Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 2004; 40: 669-674.
-
(2004)
J Hepatol
, vol.40
, pp. 669-674
-
-
Dumortier, J.1
Scoazec, J.Y.2
Chevallier, P.3
Boillot, O.4
-
20
-
-
8644285360
-
Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
-
Neff GW, Montalbano M, O'Brien CB et al. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Transplantation 2004; 78: 1303-1307.
-
(2004)
Transplantation
, vol.78
, pp. 1303-1307
-
-
Neff, G.W.1
Montalbano, M.2
O'Brien, C.B.3
-
21
-
-
19944386924
-
Pegylated versus standard interferon-alfa in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy
-
Toniutto P, Fabris C, Fumo E et al. Pegylated versus standard interferon-alfa in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy. J Gastroenterol Hepatol 2005; 20: 577-582.
-
(2005)
J Gastroenterol Hepatol
, vol.20
, pp. 577-582
-
-
Toniutto, P.1
Fabris, C.2
Fumo, E.3
-
22
-
-
11844249361
-
Applicability tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
-
Shergill AK, Khalili M, Straley S et al. Applicability tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant 2005; 5: 118-124.
-
(2005)
Am J Transplant
, vol.5
, pp. 118-124
-
-
Shergill, A.K.1
Khalili, M.2
Straley, S.3
-
23
-
-
22444439336
-
Pegylated interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
-
Babatin M, Schindel L, Burak KW. Pegylated interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy. Can J Gastroenterol 2005; 19: 359-365.
-
(2005)
Can J Gastroenterol
, vol.19
, pp. 359-365
-
-
Babatin, M.1
Schindel, L.2
Burak, K.W.3
-
24
-
-
33646815725
-
Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen
-
Biselli M, Andreone P, Gramenzi A et al. Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. Dig Liv Dis 2006; 38: 27-32.
-
(2006)
Dig Liv Dis
, vol.38
, pp. 27-32
-
-
Biselli, M.1
Andreone, P.2
Gramenzi, A.3
-
25
-
-
29544446176
-
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients
-
Oton E, Barcena R, Garcia-Garzon S et al. Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients. Transplant Proc 2005; 37: 3963-3964.
-
(2005)
Transplant Proc
, vol.37
, pp. 3963-3964
-
-
Oton, E.1
Barcena, R.2
Garcia-Garzon, S.3
-
26
-
-
17344367725
-
The efficacy of prophylactic interferon alfa 2b in preventing recurrent hepatitis C after liver transplantation
-
Sheiner PA, Boros P, Klion FM et al. The efficacy of prophylactic interferon alfa 2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28: 831-838.
-
(1998)
Hepatology
, vol.28
, pp. 831-838
-
-
Sheiner, P.A.1
Boros, P.2
Klion, F.M.3
-
27
-
-
0031887327
-
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant patients: A prospective randomized controlled trial
-
Singh N, Gayowski T, Wannstedt CF et al. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant patients: a prospective randomized controlled trial. Transplantation 1998; 65: 82-86.
-
(1998)
Transplantation
, vol.65
, pp. 82-86
-
-
Singh, N.1
Gayowski, T.2
Wannstedt, C.F.3
-
28
-
-
19944430229
-
Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
-
Chalasani N, Manzarbeitia C, Ferenci P et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials. Hepatology 2005; 41: 289-298.
-
(2005)
Hepatology
, vol.41
, pp. 289-298
-
-
Chalasani, N.1
Manzarbeitia, C.2
Ferenci, P.3
-
29
-
-
20444377637
-
Combined treatment with pegylated interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
-
Castells L, Vargas V, Allende H et al. Combined treatment with pegylated interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol 2005; 43: 53-59.
-
(2005)
J Hepatol
, vol.43
, pp. 53-59
-
-
Castells, L.1
Vargas, V.2
Allende, H.3
-
30
-
-
1642565346
-
Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
-
Ross AS, Bhan AK, Pascual M, Thiim M, Cosimi AB, Chung RT. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant 2004; 18: 166-173.
-
(2004)
Clin Transplant
, vol.18
, pp. 166-173
-
-
Ross, A.S.1
Bhan, A.K.2
Pascual, M.3
Thiim, M.4
Cosimi, A.B.5
Chung, R.T.6
-
31
-
-
26244443798
-
HCV clearance and treatment outcome in genotype 1 HCV-monoinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin
-
Moreno A, Barcena R, Garcia-Garzon S et al. HCV clearance and treatment outcome in genotype 1 HCV-monoinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin. J Hepatol 2005; 43: 783-790.
-
(2005)
J Hepatol
, vol.43
, pp. 783-790
-
-
Moreno, A.1
Barcena, R.2
Garcia-Garzon, S.3
-
32
-
-
3242780201
-
Outcomes of acute rejection after interferon therapy in liver transplant recipients
-
Saab S, Kalmaz D, Gajjar NA et al. Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl 2004; 10: 859-867.
-
(2004)
Liver Transpl
, vol.10
, pp. 859-867
-
-
Saab, S.1
Kalmaz, D.2
Gajjar, N.A.3
-
33
-
-
0037346638
-
Vascular events associated with alpha interferon therapy
-
Al-Zahrani H, Gupta V, Minden MD, Messner HA, Lipton JH. Vascular events associated with alpha interferon therapy. Leuk Lymphoma 2003; 44: 471-475.
-
(2003)
Leuk Lymphoma
, vol.44
, pp. 471-475
-
-
Al-Zahrani, H.1
Gupta, V.2
Minden, M.D.3
Messner, H.A.4
Lipton, J.H.5
-
34
-
-
0033564449
-
Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: Coincidence or true side effect?
-
Ravandi-Kashani F, Cortes J, Talpaz M, Kantarjian HM. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: Coincidence or true side effect?. Cancer 1999; 85: 2583-2588.
-
(1999)
Cancer
, vol.85
, pp. 2583-2588
-
-
Ravandi-Kashani, F.1
Cortes, J.2
Talpaz, M.3
Kantarjian, H.M.4
-
36
-
-
4644282559
-
Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin
-
Biselli M, Lorenzini S, Gramenzi A et al. Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin. Transplantation 2004; 78: 953.
-
(2004)
Transplantation
, vol.78
, pp. 953
-
-
Biselli, M.1
Lorenzini, S.2
Gramenzi, A.3
-
37
-
-
0023854279
-
Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alfa treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections
-
Kovarik J, Mayer G, Pohanka E et al. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alfa treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation 1988; 45: 402-405.
-
(1988)
Transplantation
, vol.45
, pp. 402-405
-
-
Kovarik, J.1
Mayer, G.2
Pohanka, E.3
-
38
-
-
0021339127
-
Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients
-
Kramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1984; 989-990.
-
(1984)
Lancet
, pp. 989-990
-
-
Kramer, P.1
Ten Kate, F.W.2
Bijnen, A.B.3
Jeekel, J.4
Weimar, W.5
-
39
-
-
0030795196
-
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
-
Bizollon T, Palazzo U, Ducerf C et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26: 500-504.
-
(1997)
Hepatology
, vol.26
, pp. 500-504
-
-
Bizollon, T.1
Palazzo, U.2
Ducerf, C.3
-
40
-
-
3242772980
-
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis following liver transplantation
-
Stravitz RT, Shiffman ML, Sanyal AJ et al. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis following liver transplantation. Liver Transpl 2004; 10: 850-858.
-
(2004)
Liver Transpl
, vol.10
, pp. 850-858
-
-
Stravitz, R.T.1
Shiffman, M.L.2
Sanyal, A.J.3
-
41
-
-
22844435314
-
Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C
-
Bizollon T, Pradat P, Mabrut JY et al. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Am J Transpl 2005; 5: 1909-1913.
-
(2005)
Am J Transpl
, vol.5
, pp. 1909-1913
-
-
Bizollon, T.1
Pradat, P.2
Mabrut, J.Y.3
-
42
-
-
0036850944
-
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
-
Firpi RJ, Abdelmalek MF, Soldevila-Pico C et al. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl 2002; 8: 1000-1006.
-
(2002)
Liver Transpl
, vol.8
, pp. 1000-1006
-
-
Firpi, R.J.1
Abdelmalek, M.F.2
Soldevila-Pico, C.3
-
43
-
-
0037302607
-
Long-term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence
-
Bizollon T, Ahmed SNS, Radenne S et al. Long-term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 2003; 52: 283-287.
-
(2003)
Gut
, vol.52
, pp. 283-287
-
-
Bizollon, T.1
Ahmed, S.N.S.2
Radenne, S.3
-
44
-
-
24144468662
-
Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
-
Nakagawa M, Sakamoto N, Tanabe Y et al. Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins. Gastroenterology 2005; 129: 1031-1041.
-
(2005)
Gastroenterology
, vol.129
, pp. 1031-1041
-
-
Nakagawa, M.1
Sakamoto, N.2
Tanabe, Y.3
-
45
-
-
0142182744
-
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
-
Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38: 1282-1288.
-
(2003)
Hepatology
, vol.38
, pp. 1282-1288
-
-
Watashi, K.1
Hijikata, M.2
Hosaka, M.3
Yamaji, M.4
Shimotohno, K.5
-
46
-
-
33645106470
-
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
-
Firpi RJ, Zhu H, Morelli G et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006; 12: 51-57.
-
(2006)
Liver Transpl
, vol.12
, pp. 51-57
-
-
Firpi, R.J.1
Zhu, H.2
Morelli, G.3
-
47
-
-
0035660141
-
Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens
-
Hunt J, Gordon FD, Lewis WD et al. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens. Liver Transpl 2001; 7: 1056-1063.
-
(2001)
Liver Transpl
, vol.7
, pp. 1056-1063
-
-
Hunt, J.1
Gordon, F.D.2
Lewis, W.D.3
-
48
-
-
0035881343
-
The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis
-
Papatheodoridis GV, Davies S, Dhillon AP et al. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001; 72: 412-418.
-
(2001)
Transplantation
, vol.72
, pp. 412-418
-
-
Papatheodoridis, G.V.1
Davies, S.2
Dhillon, A.P.3
-
49
-
-
0033812220
-
Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients
-
Testa G, Crippin JS, Netto GJ et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553-561.
-
(2000)
Liver Transpl
, vol.6
, pp. 553-561
-
-
Testa, G.1
Crippin, J.S.2
Netto, G.J.3
-
50
-
-
10744221228
-
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation
-
Chopra KB, Demetris AJ, Blakolmer K et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003; 76: 1487-1491.
-
(2003)
Transplantation
, vol.76
, pp. 1487-1491
-
-
Chopra, K.B.1
Demetris, A.J.2
Blakolmer, K.3
-
51
-
-
20244366386
-
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation
-
Samonakis DN, Triantos CK, Thalheimer U et al. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl 2005; 11: 386-395.
-
(2005)
Liver Transpl
, vol.11
, pp. 386-395
-
-
Samonakis, D.N.1
Triantos, C.K.2
Thalheimer, U.3
-
52
-
-
0742321955
-
Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up
-
Neumann UP, Berg T, Bahra M et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation 2004; 77: 226-231.
-
(2004)
Transplantation
, vol.77
, pp. 226-231
-
-
Neumann, U.P.1
Berg, T.2
Bahra, M.3
|